Articles, App Notes, Case Studies, & White Papers

1. 7 eCOA Design Recommendations: Insights From Sites And CRAs 2/20/2024

   Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.

2. Proven Process For Managing Clinical Trial Changes, Data Migrations 11/15/2023

   Explore how the Imperial College London was able to complete a successful migration of 14 ongoing studies, involving over 1,700 patients and 150,000+ forms, within a 16-month timeframe.

3. Why Your eTMF Needs Role-Based Access 3/2/2023

   Discover how role-based access controls can offer a way for clinical teams to answer the tough questions from regulators, investors, and other parties.

4. eTMF Systems Tell Compelling Story Of COVID-19 Vaccines 3/7/2022

   The rapid development of Covid-19 vaccines may lead more drug developers to increase their speed and agility by adopting electronic Trial Master File (eTMF) systems. In the case of Covid-19 vaccines, discover how eTMF systems tell a dramatic tale.

5. Phase 4 Trials: A Critical Component Of Post-Marketing Insight 9/16/2024

   Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

6. Unify Your Data With A Centralized eClinical Platform 3/12/2024

   Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.

7. Achieving Self Sufficiency In Data Collection For Optinose 2/12/2024

   Uncover how this specialty pharmaceutical company was able to gain control over its EDC environment by adopting a solution their team could use in-house.

8. Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases 5/13/2025

   Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.

9. 5 Important Questions To Ask Your Wearable Technology Partner 12/8/2023

   Discuss these questions with any wearable technology partner to establish a solid foundation for a successful collaboration that maximizes the potential of wearable DHTs in your clinical research endeavors.

10. Broadening Eligibility Criteria Among Cancer Clinical Trials Patients 9/17/2024

    This study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.